https://www.avient.com/sites/default/files/2021-10/microbial-susceptibility-of-various-polymers-and-evaluation.pdf
Gerber, D.
Pittol, D.
D.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
Microsoft PowerPoint - PolyOne Investor Presentation_Sidoti_3_19_13.pptx PolyOne Investor Presentation d d th l hSidoti and Company 17th Annual Emerging Growth Institutional Investor Forum March 19, 2013 Forward – Looking Statements • In this presentation, statements that are not reported financial results or other historical information are “forward‐looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
The non‐GAAP financial measures i l d dj t d EPS i b f i t t t d i ti dinclude: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income, Specialty platform gross margin percentage, adjusted operating income, return on invested capital, net debt/ EBITDA, and the exclusion of corporate p p charges in certain calculations.
EPS: $1.20 Proforma Debt Maturities & Liquidity Summary – 12/31/12 (Reflecting Financing & Spartech Acquisition) • Total Debt at 12/31/12 h $1,010 $297 $360 $300 $400 Debt Maturities As of December 31, 2012 ($ millions) Less: Cash Net Debt 213 $797 $50 $297 $100 $200 • Available Liquidity Cash $213 $800 Debt Maturities As of December 31, 2012 P f f 2/13 Fi i $50 $0 2015 2017 2020 Interest Rates: 7.500% 5.000% 7.375% Cash ABL Availability Total Liquidity $213 271 $484 $600 $400 $600 Proforma for 2/13 Financing ($ millions) Total Liquidity • Net Debt / EBITDA = 2.0x* $484 $50 $360 $0 $200 • Net Debt / EBITDA = 2.35x** $50$0 2015 2020 2023 Page 14 Interest Rates: 7.500% 7.375% 5.250% *Assumes $65 million of synergies related to Spartech acquistion **Assumes no synergies related to Spartech acquistion Use of Cash Share DividendsOrganic G Acquisitions • Repurchased 1 2 Repurchase • Introduced a Dividends • Expanding our Growth T t th t d Acquisitions • Repurchased 1.2 million shares in 2012 • 20.0 million shares are il bl f • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Expanding our sales, marketing, and technical capabilities is top priority • Investing in • Targets that expand our: • Specialty offering • End market presence • Geographic footprint available for repurchase under the current authorization Q1 2013 (20%) • Objective of maintaining and growing Investing in operational and LSS initiatives (including synergy capture) • CAPEX • Synergy opportunities • Adjacent material solutions Proforma Cash Balance = $213M N t D bt / EBITDA* 2 0X CAPEX Net Debt / EBITDA* = 2.0X *Adjusted EBITDA assumes synergies related to the Spartech acquisition are realized at close; preliminary synergies estimated at $65M and are expected to be achieved over a 3-year period Page 15 Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2024-02/AVNT Q4 2023 Earnings Presentation_For Website_with Non-GAAP.pdf
Microsoft PowerPoint - AVNT Q4 2023 Earnings Presentation v7 AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 3 R E S U L T S A N D 2 0 2 4 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A RY 1 4 , 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
ASHISH KHANDPUR PRESIDENT & CEO 4 5 PORTFOLIO TRANSFORMATION 5 7% 46% 66% 87% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2020 2023 % o f A dj us te d EB IT D A Commodity JVs Distribution Performance Products & Solutions Specialty Businesses Adjusted EBITDA from Specialty Applications SUSTAINABILITY AS A GROWTH DRIVER 7 LONG-TERM REVENUE GROWTH DRIVERS Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other 60%+ Key Growth Drivers Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other 0–2% Avient 6% END MARKET OBSERVATIONS (% OF COMPANY SALES) ENERGY 5% DEFENSE 7% TELECOMMUNICATIONS 4% HEALTHCARE 7% 8 TRANSPORTATION 10% INDUSTRIAL 16% BUILDING & CONSTRUCTION 9% CONSUMER 19% PACKAGING 23% 9 REGIONAL OBSERVATIONS (% OF COMPANY SALES) 9 US & Canada Latin America EMEA Asia 41% 36% 18% 5% Q 4 2 0 2 3 R E S U LT S Q4 2023 PERFORMANCE VS.
PY (TOTAL COMPANY) $790 $719 2022 2023 $107 $114 2022 2023 Sales Adjusted EBITDA (in millions) $0.42 $0.52 2022 2023 Adjusted EPS (in millions) - 9% + 7% + 24% Sales Adjusted EBITDA Adjusted EPS 13 Q4 2023 SEGMENT PERFORMANCE 14 CAI $491 $459 Sales (in millions) $70 $84 EBITDA SEM $301 $260 Sales $55 $49 EBITDA - 7% - 14%+20% - 11% 2022 2023 (in millions) Q4 EBITDA BRIDGE (TOTAL COMPANY) 15 $ millions CAI: Price / Mix 11 Deflation 14 SEM: Price / Mix 4 Deflation 9 Net Price Benefit 38 Cost Reductions 13 Wage Inflation (8) Other (2) Q4 2023 $114 Adjusted EBITDA Q4 2022 $ 107 Demand (34) • Demand was down, but less than in previous quarters, due to slowing pace of destocking • Positive net price benefit: o CAI – Pricing flat with favorable mix from uptick in packaging and consumer end markets and raw material deflation o SEM - Pricing flat with favorable mix from Composites and raw material deflation • Cost reductions primarily driven by reduced administrative costs and cost synergies 2 0 2 4 G U I DA N C E 2024 GUIDANCE Full Year 2024 Guidance Adjusted EBITDA $505 to $535 million Adjusted EPS $2.40 to $2.65 Interest Expense $105 to $110 million Adjusted Effective Tax Rate 23% to 25% Capital Expenditures ~$140 million 17 Q1 Adjusted EPS of $0.68 A P P E N D I X 20 Performance Additives 15% Pigments 13% TiO2 9% Dyestuffs 2% Polyethylene 10%Nylon 5% Polypropylene 4% Styrenic Block Copolymer 4% Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% EMEA 36% Asia 18% Latin America 5% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 19% Packaging 23%Industrial 16% Building and Construction 9% Telecommunications 4% Energy 5% Defense 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) Transportation 10% Healthcare 7% 22 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2023 REVENUE | $2 .0 BILLION US & Canada 34% EMEA 37% Asia 21% Latin America 8% END MARKET REGION 23 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 9% Building & Construction 10% Telecommunications 1% Energy 2% COLOR, ADDITIVES & INKS 2023 REVENUE | $1 .1 BILLION US & Canada 52% EMEA 35% Asia 13% 24 Packaging 5% Consumer 16% Healthcare 6%Industrial 16% Transportation 12% Telecommunications 9% Energy 10% Defense 18% Building & Construction 8% END MARKET REGION SPECIALTY ENGINEERED MATERIALS Packaging 32% Consumer 26% Healthcare 9% Industrial 13% Building & Construction 6% Telecommunications 2% Energy 2% Defense 1% Asia (18% of sales) Transportation 9% 2023 AVIENT REGIONAL SALES Packaging 25% Consumer 13% Healthcare 5% Industrial 18% Building & Construction 9% Energy 5% Defense 8% EMEA (36% of sales)Transportation 13% Packaging 13% Consumer 22% Healthcare 10% Industrial 16% Building & Construction 12% Energy 6% Defense 8% US & Canada (41% of sales) Transportation 9% Packaging 59% Consumer 22% Healthcare 2% Industrial 8% Building & Construction 4% LATAM (5% of sales) Transportation 5% Telecommunications 4% Telecommunications 4% 25 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2021-06/fl.us-.datasheet-nomex-meta-aramid.pdf
Key Features • Excellent heat & flame resistance • High chemical resistance • Low thermal shrinkage • Self-extinguishing flame retardant properties • Soft-hand yields good textile properties Disadvantages • Low tenacity • Low modulus FIBER-LINE® PROCESS FOR NOMEX® META-ARAMID • Coating • Twisting • Precision Winding FIBER-LINE® NOMEX® PRODUCTS • Packing Yarn • Wire Harness Yarn • Industrial Fabric Yarn Property UOM Value Breaking Tenacity g/d 5.0 Specific Gravity Ratio 1.38 Elongation @ Break % 30.0 Tensile Modulus g/d 125 Moisture Regain* % 4.5 Creep** % N/A Shrinkage*** % .4 Melt Point °C None Decomposition Temp.
NOMEX® META-ARAMID DATA META-ARAMID (HM) BARE FIBER PERFORMANCE * Equilibrium moisture regain @ 55% RH ** Creep @ 40%-58% ultimate tensile strength *** Shrinkage in dry air @ 177 C for 30 minutes MOVING HIGH PERFORMANCE FIBERS FORWARD ABOUT FIBER-LINE® LOCATIONS Headquarters, R&D, Manufacturing FIBER-LINE® LLC 3050 Campus Drive Hatfield, PA 19440 +1 215.997.9181 fiber@fiber-line.com Manufacturing Operations FIBER-LINE® LLC 280 Performance Drive SE Hickory, NC 28602 +1 828.326.8700 fiber@fiber-line.com EMEA & Asia Pacific Operations FIBER-LINE® INTERNATIONAL B.V.
https://www.avient.com/sites/default/files/2021-06/fl.a4.datasheet-novoloid.pdf
Abrasion Resistance Ultraviolet (UV) Resistance Flame Resistance Chemical Resistance (Acid Chemical Resistance (Alkali) Chemical Resistance (Organic Solvent) Strength Retention (H2O) O P P P P P P Property UOM Value Breaking Tenacity g/d 1.5 Specific Gravity Ratio 1.27 Elongation @ Break % 30.0 - 40.0 Tensile Modulus g/d 2.5 - 5.0 Moisture Regain* % 6.0 Creep** % N/A Shrinkage*** % < 0.1 Melt Point °C N/A Decomposition Temp.
MOVING HIGH PERFORMANCE FIBERS FORWARD LOCATIONS Headquarters, R&D, Manufacturing FIBER-LINE® LLC 3050 Campus Drive Hatfield, PA 19440 +1 215.997.9181 fiber@fiber-line.com Manufacturing Operations FIBER-LINE® LLC 280 Performance Drive SE Hickory, NC 28602 +1 828.326.8700 fiber@fiber-line.com EMEA & Asia Pacific Operations FIBER-LINE® INTERNATIONAL B.V.
https://www.avient.com/sites/default/files/2021-07/fiber-line-global-product-selection-guide.pdf
FIBER-LINE™ High Performance Synthetic Fibers PRODUCT SELECTION GUIDE FIBER-LINE™ HIGH PERFORMANCE SYNTHETIC FIBERS Kevlar® Para-Aramid Nomex® Meta-Aramid Vectran® LCP Zylon® PBO Carbon Fiber UHMWPE PET Polyester Fiberglass Novoloid Technora® Filament Yarn TECHNICAL PROPERTIES Standard Modulus High Modulus Standard Modulus Standard Modulus High Modulus Standard Modulus High Modulus Standard Modulus Standard Modulus High Modulus High Tenacity Low Shrink E-Glass S-Glass Standard Modulus Standard Modulus Breaking Tenacity (g/d) 23.0 23.6 5.0 23.0 30.0 42.0 42.0 23.0 28.0 38 9.3 8.4 6.0 - 7.3 6.7 - 9.4 1.5 28.0 Specific Gravity (Ratio) 1.44 1.44 1.38 1.40 1.40 1.54 1.56 1.80 0.97 0.97 1.38 1.38 2.58 2.48 1.27 1.39 Elongation at Break (%) 3.5 2.5 30.0 3.8 2.8 3.5 2.5 1.5 3.5 3.1 14.6 19.5 3.5 5.5 30.0 - 40.0 4.6 Tensile Modulus (g/d) 555 885 125 600 830 1200 1800 1480 850 1250 120 70 200–275 140–170 2.5–5.0 590 Equilibrium Moisture Regain at 55% RH (%) 5.0 5.0 4.5
https://www.avient.com/sites/default/files/2021-02/avient-ir-presentation-goldman-sachs-and-morgan-stanley.pdf
Microsoft PowerPoint - Avient February IR Meetings AVIENT CORPORATION (NYSE: AVNT) F E B R U A R Y 1 7 - 1 8 , 2 0 2 1 I N V E S T O R M E E T I N G S H O S T E D B Y G O L D M A N S A C H S A N D M O R G A N S T A N L E Y DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
D is t. ) R P M P P G K W R F U L A V Y G C P IF F F M C H X L H U N E M N F O E E C L K R A S C L A S H C E G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of February 5, 2021 Avient reflects 2021 estimated revenue of $4,100M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Our free cash flow supports shareholder value creation through investing in R&D for organic growth, completing bolt-on acquisitions, and returning cash to shareholders via our dividend program and opportunistic share repurchases. 26 1.
https://www.avient.com/sites/default/files/2021-09/avnt-q2-2021-earnings-presentation.pdf
Microsoft PowerPoint - AVNT Q2 2021 Earnings Presentation - Website AVIENT CORPORATION S E C O N D Q U A R T E R 2 0 2 1 R E S U LT S (NYSE: AVNT) J U LY 3 0 , 2 0 2 1 DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
D is t. ) K W R P P G A V Y F U L R P M G C P H X L F M C H U N IF F E C L A S H K R A E M N C E S C L A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of July 28, 2021 Avient reflects 2021 estimated revenue of $4,650M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Our free cash flow supports shareholder value creation through investing in R&D for organic growth, completing bolt-on acquisitions, and returning cash to shareholders via our dividend program and opportunistic share repurchases. 24 1.
https://www.avient.com/sites/default/files/2022-04/Asia SEM Healthcare Product Selection Guide_CN.pdf
在对普通消毒剂的耐受性方面优于PC/ABS、 PC/PET和COPE 暴露在普通医院消毒剂下72小时后仍能保持 抗拉强度,相较于PC混合物和COPE,具有 更出色的长期耐化学性 具有良好的抗冲击性和耐热性 有自然色等级、标准医用颜色或定制预着色 产品可供选择 • • • • 医疗设备外壳 核磁共振成像、X射线、CT扫描仪部件 手术器械,如吻合器、解剖器、剪刀等 自动注射笔 测试项 比重 熔体流动指数 (230OC, 2.16KG) 抗拉强度 挠曲强度 挠曲模量 冲击强度 缺口,IZOD 测试项 方法 ASTM D-792 ASTM D-1238 ASTM D-638 ASTM D-790 ASTM D-790 ASTM D-256 ASTM D-257 单位 -- g/10min MPa MPa MPa J/m Ohms/sq.
https://www.avient.com/sites/default/files/resources/PolyOne%25202012%2520Annual%2520Report.pdf
Stephen D.
STEPHEN D.
Stephen D.